In the United States, the price of droxidopa, a medication used to treat neurogenic orthostatic hypotension (NOH), can vary significantly. For example, a 30-day supply of 200 mg capsules has been listed at approximately $1,200 to $1,400 for cash-paying customers [1]. The exact cost can depend on factors such as the dosage, quantity, and the pharmacy where it is purchased [1].
How much does a 30-day supply of droxidopa cost?
A 30-day supply of droxidopa, particularly the 200 mg capsule formulation, typically ranges from $1,200 to over $1,400 for individuals paying out-of-pocket [1]. This pricing is reflective of the medication's specialized nature and its indication for a specific medical condition.
Can I get financial assistance for droxidopa?
Financial assistance programs may be available to help reduce the cost of droxidopa for eligible patients. Pharmaceutical manufacturers often provide patient assistance programs that offer co-pay cards or free medication to those who meet certain income and insurance criteria [1]. Checking with the drug's manufacturer or consulting with a healthcare provider or pharmacist about available support can be beneficial [1].
What is droxidopa used for?
Droxidopa is prescribed to treat symptomatic neurogenic orthostatic hypotension (NOH), a condition characterized by a significant drop in blood pressure upon standing, leading to symptoms like dizziness and lightheadedness [1]. It works by converting to norepinephrine, a neurotransmitter that helps constrict blood vessels and raise blood pressure [1].
When does droxidopa's patent expire?
Information regarding the specific patent expiry dates for droxidopa is available through specialized resources. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can include details on when market exclusivity is set to end [2].
What are the common side effects of droxidopa?
Patients taking droxidopa may experience several side effects. These can include headache, dizziness, nausea, hypertension (high blood pressure), and pain [1]. It is important for patients to discuss any potential side effects with their healthcare provider, as adjustments to dosage or management strategies may be necessary [1].
How does droxidopa work in the body?
Droxidopa is a prodrug, meaning it is converted into an active substance in the body. Once administered, it is metabolized into norepinephrine, an endogenous catecholamine. Norepinephrine then acts on alpha-adrenergic receptors in the periphery, leading to vasoconstriction. This effect helps to increase blood pressure and alleviate the symptoms of NOH [1].
What are the alternatives to droxidopa for NOH?
While droxidopopa is an option for NOH, other treatment strategies exist. These can include non-pharmacological interventions such as increased fluid and salt intake, and the use of compression garments. Pharmacological alternatives may involve medications like fludrocortisone and midodrine, though these have different mechanisms of action and potential side effect profiles [1]. The choice of treatment is individualized based on patient symptoms, medical history, and response to therapy.
---
Sources
[1] Drug information from various pharmacies and medical resources.
[2] DrugPatentWatch.com